Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Akoustis Technologies, Inc.AKTS · Entity 88229 | Director · Chief Executive Officer | January 29, 2024 | January 31, 2024 |
| Blue Laser Fusion, Inc.NONE · Entity 107871 | Director | September 30, 2026 | October 05, 2026 |
| Palomino Laboratories Inc.NONE · Entity 9910 | Director · President and CEO · 10% owner | September 29, 2025 | October 27, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Akoustis Technologies, Inc.
Report date January 29, 2024 · Filed January 31, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 2,222,775 |
Reported balance
After 2024-01-29 transaction · row 1
1 source rowRow 1 · 2024-01-29 · Purchase · Acquired 1,310,000 · Balance 2,222,775 F1: Represents shares of Common Stock purchased by the reporting person at the public offering price in connection with the issuer's underwritten public offering of Common Stock, which closed on January 29, 2024. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares of Common Stock purchased by the reporting person at the public offering price in connection with the issuer's underwritten public offering of Common Stock, which closed on January 29, 2024.
Blue Laser Fusion, Inc.
Report date September 30, 2026 · Filed October 05, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 3,637 |
Reported balance
After 2026-09-30 transaction · row 1
1 source rowRow 1 · 2026-09-30 · Other · Acquired 3,637 · Balance 3,637 F1: Pursuant to a subscription agreement, the Reporting Person and Erika C. Cerini Honick purchased 3,637 shares of common stock of the Issuer in the second closing of the Issuer's private placement offering at a price of $27.50 per share. |
Filing footnotes · ownership attribution and instrument terms
F1: Pursuant to a subscription agreement, the Reporting Person and Erika C. Cerini Honick purchased 3,637 shares of common stock of the Issuer in the second closing of the Issuer's private placement offering at a price of $27.50 per share.
Palomino Laboratories Inc.
Report date September 29, 2025 · Filed October 27, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 4,666,666 |
Reported balance
After 2025-09-29 transaction · row 1
1 source rowRow 1 · 2025-09-29 · Other · Acquired 3,833,333 · Balance 4,666,666 F1: Per the terms of an Agreement and Plan of Merger, dated September 29, 2025, Palomino Acquisition Co., a subsidiary of Issuer, merged into Rhino Subsidiary Inc. (f/k/a Palomino Laboratories Inc., "Pre-Merger Palomino"). Mr. Shealy, as a shareholder of Pre-Merger Palomino, received 3,000,000 shares of common stock, par value $0.0001 per share, of Issuer ("Common Stock") in exchange for his Pre-Merger Palomino shares. On September 29, 2025, Issuer closed a private placement offering and, in connection therewith, Mr. Shealy converted his SAFEs into 833,333 Units in the offering at a price of $1.20 per Unit. Each Unit consists of one share of the Common Stock and one warrant to purchase one share of Common Stock at an exercise price of $1.50. The warrants expire on the first anniversary of the date the Common Stock is admitted for trading or listed on an Approved Market (as defined in the warrant agreement). |
| WarrantsSEC Table II · derivative / convertible security · Conversion / exercise price $1.50 | Direct | 4,666,666 |
Reported balance
After 2025-09-29 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2025-09-29 · Sale · Acquired 833,333 · Balance 4,666,666 F1: Per the terms of an Agreement and Plan of Merger, dated September 29, 2025, Palomino Acquisition Co., a subsidiary of Issuer, merged into Rhino Subsidiary Inc. (f/k/a Palomino Laboratories Inc., "Pre-Merger Palomino"). Mr. Shealy, as a shareholder of Pre-Merger Palomino, received 3,000,000 shares of common stock, par value $0.0001 per share, of Issuer ("Common Stock") in exchange for his Pre-Merger Palomino shares. On September 29, 2025, Issuer closed a private placement offering and, in connection therewith, Mr. Shealy converted his SAFEs into 833,333 Units in the offering at a price of $1.20 per Unit. Each Unit consists of one share of the Common Stock and one warrant to purchase one share of Common Stock at an exercise price of $1.50. The warrants expire on the first anniversary of the date the Common Stock is admitted for trading or listed on an Approved Market (as defined in the warrant agreement). |
Filing footnotes · ownership attribution and instrument terms
F1: Per the terms of an Agreement and Plan of Merger, dated September 29, 2025, Palomino Acquisition Co., a subsidiary of Issuer, merged into Rhino Subsidiary Inc. (f/k/a Palomino Laboratories Inc., "Pre-Merger Palomino"). Mr. Shealy, as a shareholder of Pre-Merger Palomino, received 3,000,000 shares of common stock, par value $0.0001 per share, of Issuer ("Common Stock") in exchange for his Pre-Merger Palomino shares. On September 29, 2025, Issuer closed a private placement offering and, in connection therewith, Mr. Shealy converted his SAFEs into 833,333 Units in the offering at a price of $1.20 per Unit. Each Unit consists of one share of the Common Stock and one warrant to purchase one share of Common Stock at an exercise price of $1.50. The warrants expire on the first anniversary of the date the Common Stock is admitted for trading or listed on an Approved Market (as defined in the warrant agreement).
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 30, 2026 Filed Oct 5, 2026 17:23 UTC | Blue Laser Fusion, Inc. NONE · Entity 107871 | OtherCommon Stock | 3,637 | $27.50 | $100,017.50 |
DisclosureSEC source: 0001493152-26-045725 · ownership.xml · nonDerivative · entry 1 Shealy Jeffrey B. · CIK 0001700683 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,637 F1 · kind: Pursuant to a subscription agreement, the Reporting Person and Erika C. Cerini Honick purchased 3,637 shares of common stock of the Issuer in the second closing of the Issuer's private placement offering at a price of $27.50 per share. Read SEC document |
| September 04, 2026 Filed Sep 9, 2026 19:22 UTC | Blue Laser Fusion, Inc. NONE · Entity 107871 | GrantStock Option (right to buy) · Derivative | 22,098 | Not disclosed Strike: $2.10 | Not disclosed |
DisclosureSEC source: 0001493152-26-041949 · ownership.xml · derivative · entry 1 Shealy Jeffrey B. · CIK 0001700683 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,098 Underlying: Common Stock · 22,098 shares Expires 2036-03-04 F1 · price: Received in the merger of Blue Laser Fusion Acquisition Co., a subsidiary of the issuer, with and into Blue Laser Subsidiary Inc. (f/k/a Blue Laser Fusion Inc., "Pre-Merger BLF"), pursuant to the Agreement and Plan of Merger, dated September 4, 2026, in exchange for an option to acquire 35,000 shares of common stock of Pre-Merger BLF for $1.32 per share. The option vests in 48 equal monthly installments beginning on February 1, 2026. F1 · derivative.exercise_date: Received in the merger of Blue Laser Fusion Acquisition Co., a subsidiary of the issuer, with and into Blue Laser Subsidiary Inc. (f/k/a Blue Laser Fusion Inc., "Pre-Merger BLF"), pursuant to the Agreement and Plan of Merger, dated September 4, 2026, in exchange for an option to acquire 35,000 shares of common stock of Pre-Merger BLF for $1.32 per share. The option vests in 48 equal monthly installments beginning on February 1, 2026. Read SEC document |
| September 29, 2025 Filed Oct 27, 2025 20:32 UTC | Palomino Laboratories Inc. NONE · Entity 9910 | SaleWarrants · Derivative | 833,333 | $1.20 Strike: $1.50 | $999,999.60 |
DisclosureSEC source: 0001493152-25-019755 · ownership.xml · derivative · entry 2 Shealy Jeffrey B. · CIK 0001700683 · Director · President and CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,666,666 Underlying: Common Stock · 833,333 shares Expires not disclosed F1 · kind: Per the terms of an Agreement and Plan of Merger, dated September 29, 2025, Palomino Acquisition Co., a subsidiary of Issuer, merged into Rhino Subsidiary Inc. (f/k/a Palomino Laboratories Inc., "Pre-Merger Palomino"). Mr. Shealy, as a shareholder of Pre-Merger Palomino, received 3,000,000 shares of common stock, par value $0.0001 per share, of Issuer ("Common Stock") in exchange for his Pre-Merger Palomino shares. On September 29, 2025, Issuer closed a private placement offering and, in connection therewith, Mr. Shealy converted his SAFEs into 833,333 Units in the offering at a price of $1.20 per Unit. Each Unit consists of one share of the Common Stock and one warrant to purchase one share of Common Stock at an exercise price of $1.50. The warrants expire on the first anniversary of the date the Common Stock is admitted for trading or listed on an Approved Market (as defined in the warrant agreement). F1 · derivative.expiration_date: Per the terms of an Agreement and Plan of Merger, dated September 29, 2025, Palomino Acquisition Co., a subsidiary of Issuer, merged into Rhino Subsidiary Inc. (f/k/a Palomino Laboratories Inc., "Pre-Merger Palomino"). Mr. Shealy, as a shareholder of Pre-Merger Palomino, received 3,000,000 shares of common stock, par value $0.0001 per share, of Issuer ("Common Stock") in exchange for his Pre-Merger Palomino shares. On September 29, 2025, Issuer closed a private placement offering and, in connection therewith, Mr. Shealy converted his SAFEs into 833,333 Units in the offering at a price of $1.20 per Unit. Each Unit consists of one share of the Common Stock and one warrant to purchase one share of Common Stock at an exercise price of $1.50. The warrants expire on the first anniversary of the date the Common Stock is admitted for trading or listed on an Approved Market (as defined in the warrant agreement). Read SEC document |
| September 29, 2025 Filed Oct 27, 2025 20:32 UTC | Palomino Laboratories Inc. NONE · Entity 9910 | OtherCommon Stock | 3,833,333 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001493152-25-019755 · ownership.xml · nonDerivative · entry 1 Shealy Jeffrey B. · CIK 0001700683 · Director · President and CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,666,666 F1 · kind: Per the terms of an Agreement and Plan of Merger, dated September 29, 2025, Palomino Acquisition Co., a subsidiary of Issuer, merged into Rhino Subsidiary Inc. (f/k/a Palomino Laboratories Inc., "Pre-Merger Palomino"). Mr. Shealy, as a shareholder of Pre-Merger Palomino, received 3,000,000 shares of common stock, par value $0.0001 per share, of Issuer ("Common Stock") in exchange for his Pre-Merger Palomino shares. On September 29, 2025, Issuer closed a private placement offering and, in connection therewith, Mr. Shealy converted his SAFEs into 833,333 Units in the offering at a price of $1.20 per Unit. Each Unit consists of one share of the Common Stock and one warrant to purchase one share of Common Stock at an exercise price of $1.50. The warrants expire on the first anniversary of the date the Common Stock is admitted for trading or listed on an Approved Market (as defined in the warrant agreement). F1 · price: Per the terms of an Agreement and Plan of Merger, dated September 29, 2025, Palomino Acquisition Co., a subsidiary of Issuer, merged into Rhino Subsidiary Inc. (f/k/a Palomino Laboratories Inc., "Pre-Merger Palomino"). Mr. Shealy, as a shareholder of Pre-Merger Palomino, received 3,000,000 shares of common stock, par value $0.0001 per share, of Issuer ("Common Stock") in exchange for his Pre-Merger Palomino shares. On September 29, 2025, Issuer closed a private placement offering and, in connection therewith, Mr. Shealy converted his SAFEs into 833,333 Units in the offering at a price of $1.20 per Unit. Each Unit consists of one share of the Common Stock and one warrant to purchase one share of Common Stock at an exercise price of $1.50. The warrants expire on the first anniversary of the date the Common Stock is admitted for trading or listed on an Approved Market (as defined in the warrant agreement). Read SEC document |
| January 29, 2024 Filed Jan 31, 2024 18:39 UTC | Akoustis Technologies, Inc. AKTS · Entity 88229 | PurchaseCommon Stock | 1,310,000 | $0.50 | $655,000.00 |
DisclosureSEC source: 0001562180-24-000865 · primarydocument.xml · nonDerivative · entry 1 Shealy Jeffrey B. · CIK 0001700683 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,222,775 F1 · kind: Represents shares of Common Stock purchased by the reporting person at the public offering price in connection with the issuer's underwritten public offering of Common Stock, which closed on January 29, 2024. Read SEC document |
| September 26, 2023 Filed Sep 28, 2023 17:00 UTC | Akoustis Technologies, Inc. AKTS · Entity 88229 | GrantCommon Stock | 80,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-23-007052 · primarydocument.xml · nonDerivative · entry 1 Shealy Jeffrey B. · CIK 0001700683 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 912,775 Read SEC document |
| January 24, 2023 Filed Jan 24, 2023 16:06 UTC | Akoustis Technologies, Inc. AKTS · Entity 88229 | GrantCommon Stock | 327,273 | $2.75 | $900,000.75 |
DisclosureSEC source: 0001562180-23-000566 · primarydocument.xml · nonDerivative · entry 1 Shealy Jeffrey B. · CIK 0001700683 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 832,775 Read SEC document |
| December 20, 2022 Filed Dec 21, 2022 17:03 UTC | Akoustis Technologies, Inc. AKTS · Entity 88229 | SaleCommon Stock | 2,340 | $2.84 | $6,645.60 |
DisclosureSEC source: 0001562180-22-008408 · primarydocument.xml · nonDerivative · entry 1 Shealy Jeffrey B. · CIK 0001700683 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 505,502 F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.78 to $2.90, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 28, 2022 Filed Nov 28, 2022 17:02 UTC | Akoustis Technologies, Inc. AKTS · Entity 88229 | SaleCommon Stock | 1,950 | $3.54 | $6,903.00 |
DisclosureSEC source: 0001562180-22-007906 · primarydocument.xml · nonDerivative · entry 1 Shealy Jeffrey B. · CIK 0001700683 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 507,842 F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.51 to $3.59, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 21, 2022 Filed Nov 23, 2022 17:00 UTC | Akoustis Technologies, Inc. AKTS · Entity 88229 | GrantCommon Stock | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-22-007883 · primarydocument.xml · nonDerivative · entry 1 Shealy Jeffrey B. · CIK 0001700683 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 509,792 Read SEC document |
| September 09, 2022 Filed Sep 12, 2022 17:01 UTC | Akoustis Technologies, Inc. AKTS · Entity 88229 | SaleCommon Stock | 3,900 | $4.30 | $16,770.00 |
DisclosureSEC source: 0001562180-22-006613 · primarydocument.xml · nonDerivative · entry 1 Shealy Jeffrey B. · CIK 0001700683 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 459,792 F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.21 to $4.34, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 29, 2022 Filed Aug 31, 2022 17:03 UTC | Akoustis Technologies, Inc. AKTS · Entity 88229 | SaleCommon Stock | 3,900 | $4.54 | $17,706.00 |
DisclosureSEC source: 0001562180-22-006395 · primarydocument.xml · nonDerivative · entry 1 Shealy Jeffrey B. · CIK 0001700683 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 463,692 F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.49 to $4.61, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 10, 2022 Filed Feb 14, 2022 09:08 UTC | Akoustis Technologies, Inc. AKTS · Entity 88229 | Exercise / conversionStock Option (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $7.12 | $0.00 |
DisclosureSEC source: 0001562180-22-001438 · primarydocument.xml · derivative · entry 2 Shealy Jeffrey B. · CIK 0001700683 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,000 Underlying: Common Stock · 15,000 shares Expires 2024-09-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 10, 2022 Filed Feb 14, 2022 09:08 UTC | Akoustis Technologies, Inc. AKTS · Entity 88229 | Exercise / conversionCommon Stock | 15,000 | $7.12 | $106,800.00 |
DisclosureSEC source: 0001562180-22-001438 · primarydocument.xml · nonDerivative · entry 1 Shealy Jeffrey B. · CIK 0001700683 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 467,592 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 17, 2021 Filed Dec 21, 2021 17:00 UTC | Akoustis Technologies, Inc. AKTS · Entity 88229 | SaleCommon Stock | 13,928 | $7.01 | $97,635.28 |
DisclosureSEC source: 0001562180-21-007824 · primarydocument.xml · nonDerivative · entry 1 Shealy Jeffrey B. · CIK 0001700683 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 452,592 F1 · kind: These transactions were effected in order to cover the reporting person's tax liability incurred in connection with the vesting of restricted stock units on August 28, 2021, September 27, 2021, November 27, 2021, and December 20, 2021, and incurred in connection with these transactions. F2 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.01 to $7.04, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| September 09, 2021 Filed Sep 10, 2021 17:07 UTC | Akoustis Technologies, Inc. AKTS · Entity 88229 | GrantStock Options (Right to buy) · Derivative | 50,000 | $0.00 Strike: $10.15 | $0.00 |
DisclosureSEC source: 0001562180-21-005904 · primarydocument.xml · derivative · entry 2 Shealy Jeffrey B. · CIK 0001700683 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2028-09-09 F1 · derivative.exercise_date: The Stock Options vest in five equal annual installments beginning on September 09, 2022. Read SEC document |
| September 09, 2021 Filed Sep 10, 2021 17:07 UTC | Akoustis Technologies, Inc. AKTS · Entity 88229 | GrantCommon Stock | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-21-005904 · primarydocument.xml · nonDerivative · entry 1 Shealy Jeffrey B. · CIK 0001700683 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 466,520 Read SEC document |
| April 08, 2021 Filed Apr 9, 2021 17:02 UTC | Akoustis Technologies, Inc. AKTS · Entity 88229 | SaleCommon Stock | 100,000 | $12.03 | $1,203,000.00 |
DisclosureSEC source: 0001562180-21-002772 · primarydocument.xml · nonDerivative · entry 3 Shealy Jeffrey B. · CIK 0001700683 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 416,520 F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan. F3 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.75 to $12.19, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| April 07, 2021 Filed Apr 9, 2021 17:02 UTC | Akoustis Technologies, Inc. AKTS · Entity 88229 | SaleCommon Stock | 100,000 | $12.51 | $1,251,000.00 |
DisclosureSEC source: 0001562180-21-002772 · primarydocument.xml · nonDerivative · entry 2 Shealy Jeffrey B. · CIK 0001700683 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 516,520 F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.13 to $13.32, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| March 16, 2021 Filed Mar 17, 2021 17:15 UTC | Akoustis Technologies, Inc. AKTS · Entity 88229 | SaleCommon Stock | 100,000 | $13.32 | $1,332,000.00 |
DisclosureSEC source: 0001562180-21-002301 · primarydocument.xml · nonDerivative · entry 2 Shealy Jeffrey B. · CIK 0001700683 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 936,239 F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan. F3 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.80 to $13.75, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| March 15, 2021 Filed Mar 17, 2021 17:15 UTC | Akoustis Technologies, Inc. AKTS · Entity 88229 | SaleCommon Stock | 100,000 | $13.83 | $1,383,000.00 |
DisclosureSEC source: 0001562180-21-002301 · primarydocument.xml · nonDerivative · entry 1 Shealy Jeffrey B. · CIK 0001700683 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,036,239 F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.52 to $14.34, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 08, 2021 Filed Feb 10, 2021 17:02 UTC | Akoustis Technologies, Inc. AKTS · Entity 88229 | SaleCommon Stock | 15,000 | $18.00 | $270,000.00 |
DisclosureSEC source: 0001562180-21-001050 · primarydocument.xml · nonDerivative · entry 1 Shealy Jeffrey B. · CIK 0001700683 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,136,239 Read SEC document |
| February 04, 2021 Filed Apr 9, 2021 17:02 UTC | Akoustis Technologies, Inc. AKTS · Entity 88229 | GiftCommon Stock | 319,719 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-21-002772 · primarydocument.xml · nonDerivative · entry 1 Shealy Jeffrey B. · CIK 0001700683 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 831,520 Read SEC document |
| December 17, 2020 Filed Dec 18, 2020 17:03 UTC | Akoustis Technologies, Inc. AKTS · Entity 88229 | SaleCommon Stock | 9,000 | $11.34 | $102,060.00 |
DisclosureSEC source: 0001562180-20-007365 · primarydocument.xml · nonDerivative · entry 2 Shealy Jeffrey B. · CIK 0001700683 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,151,239 F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan. F3 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.88 to $11.78, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| December 16, 2020 Filed Dec 18, 2020 17:03 UTC | Akoustis Technologies, Inc. AKTS · Entity 88229 | SaleCommon Stock | 25,000 | $10.25 | $256,250.00 |
DisclosureSEC source: 0001562180-20-007365 · primarydocument.xml · nonDerivative · entry 1 Shealy Jeffrey B. · CIK 0001700683 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,160,239 F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.80 to $10.69, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| December 10, 2020 Filed Dec 11, 2020 17:04 UTC | Akoustis Technologies, Inc. AKTS · Entity 88229 | SaleCommon Stock | 50,000 | $8.51 | $425,500.00 |
DisclosureSEC source: 0001562180-20-007213 · primarydocument.xml · nonDerivative · entry 2 Shealy Jeffrey B. · CIK 0001700683 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,185,239 F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan. F3 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.23 to $8.73, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| December 09, 2020 Filed Dec 11, 2020 17:04 UTC | Akoustis Technologies, Inc. AKTS · Entity 88229 | SaleCommon Stock | 50,000 | $8.51 | $425,500.00 |
DisclosureSEC source: 0001562180-20-007213 · primarydocument.xml · nonDerivative · entry 1 Shealy Jeffrey B. · CIK 0001700683 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,235,239 F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.28 to $8.75, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 24, 2020 Filed Nov 25, 2020 17:02 UTC | Akoustis Technologies, Inc. AKTS · Entity 88229 | SaleCommon Stock | 50,000 | $7.71 | $385,500.00 |
DisclosureSEC source: 0001562180-20-006928 · primarydocument.xml · nonDerivative · entry 2 Shealy Jeffrey B. · CIK 0001700683 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,285,239 F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan. F3 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.52 to $7.91, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 23, 2020 Filed Nov 25, 2020 17:02 UTC | Akoustis Technologies, Inc. AKTS · Entity 88229 | SaleCommon Stock | 50,000 | $7.77 | $388,500.00 |
DisclosureSEC source: 0001562180-20-006928 · primarydocument.xml · nonDerivative · entry 1 Shealy Jeffrey B. · CIK 0001700683 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,335,239 F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.61 to $7.92, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| October 22, 2020 Filed Oct 23, 2020 17:04 UTC | Akoustis Technologies, Inc. AKTS · Entity 88229 | SaleCommon Stock | 50,000 | $7.84 | $392,000.00 |
DisclosureSEC source: 0001562180-20-006425 · primarydocument.xml · nonDerivative · entry 2 Shealy Jeffrey B. · CIK 0001700683 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,385,239 F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan. F3 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.73 to $8.04, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| October 21, 2020 Filed Oct 23, 2020 17:04 UTC | Akoustis Technologies, Inc. AKTS · Entity 88229 | SaleCommon Stock | 50,000 | $7.76 | $388,000.00 |
DisclosureSEC source: 0001562180-20-006425 · primarydocument.xml · nonDerivative · entry 1 Shealy Jeffrey B. · CIK 0001700683 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,435,239 F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.65 to 7.95, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| October 01, 2020 Filed Oct 2, 2020 17:01 UTC | Akoustis Technologies, Inc. AKTS · Entity 88229 | SaleCommon Stock | 50,000 | $8.07 | $403,500.00 |
DisclosureSEC source: 0001562180-20-006236 · primarydocument.xml · nonDerivative · entry 2 Shealy Jeffrey B. · CIK 0001700683 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,485,239 F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan. F4 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.98 to $8.23, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| September 30, 2020 Filed Oct 2, 2020 17:01 UTC | Akoustis Technologies, Inc. AKTS · Entity 88229 | SaleCommon Stock | 50,000 | $8.39 | $419,500.00 |
DisclosureSEC source: 0001562180-20-006236 · primarydocument.xml · nonDerivative · entry 1 Shealy Jeffrey B. · CIK 0001700683 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,535,239 F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.09 to $8.62, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · balance_after: Reflects 1,344,323 shares transferred to the Reporting Person's ex-spouse pursuant to a settlement agreement entered into in connection with a divorce granted on September 22, 2020. Read SEC document |
| September 24, 2020 Filed Sep 25, 2020 17:09 UTC | Akoustis Technologies, Inc. AKTS · Entity 88229 | SaleCommon Stock | 7,500 | $8.02 | $60,150.00 |
DisclosureSEC source: 0001562180-20-006105 · primarydocument.xml · nonDerivative · entry 2 Shealy Jeffrey B. · CIK 0001700683 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,929,562 F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan. F3 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.87 to $8.18, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| September 23, 2020 Filed Sep 25, 2020 17:09 UTC | Akoustis Technologies, Inc. AKTS · Entity 88229 | SaleCommon Stock | 25,000 | $8.20 | $205,000.00 |
DisclosureSEC source: 0001562180-20-006105 · primarydocument.xml · nonDerivative · entry 1 Shealy Jeffrey B. · CIK 0001700683 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,937,062 F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.94 to $8.48, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 28, 2020 Filed Sep 1, 2020 17:06 UTC | Akoustis Technologies, Inc. AKTS · Entity 88229 | GrantStock Options (Right to buy) · Derivative | 50,000 | $0.00 Strike: $8.11 | $0.00 |
DisclosureSEC source: 0001562180-20-005726 · primarydocument.xml · derivative · entry 2 Shealy Jeffrey B. · CIK 0001700683 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2027-08-28 F1 · derivative.exercise_date: The Stock Options vest in five equal annual installments beginning on August 28, 2021. Read SEC document |
| August 28, 2020 Filed Sep 1, 2020 17:06 UTC | Akoustis Technologies, Inc. AKTS · Entity 88229 | GrantCommon Stock | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-20-005726 · primarydocument.xml · nonDerivative · entry 1 Shealy Jeffrey B. · CIK 0001700683 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,962,062 Read SEC document |
| June 25, 2020 Filed Jun 26, 2020 17:09 UTC | Akoustis Technologies, Inc. AKTS · Entity 88229 | SaleCommon Stock | 9,000 | $8.37 | $75,330.00 |
DisclosureSEC source: 0001562180-20-004704 · primarydocument.xml · nonDerivative · entry 2 Shealy Jeffrey B. · CIK 0001700683 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,912,062 F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan originally adopted by the reporting person on December 19, 2019 (as amended on May 15, 2020). F3 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.11 to $8.58, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 24, 2020 Filed Jun 26, 2020 17:09 UTC | Akoustis Technologies, Inc. AKTS · Entity 88229 | SaleCommon Stock | 25,000 | $8.42 | $210,500.00 |
DisclosureSEC source: 0001562180-20-004704 · primarydocument.xml · nonDerivative · entry 1 Shealy Jeffrey B. · CIK 0001700683 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,921,062 F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan originally adopted by the reporting person on December 19, 2019 (as amended on May 15, 2020). F2 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.17 to $8.77, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 17, 2020 Filed Jun 18, 2020 16:49 UTC | Akoustis Technologies, Inc. AKTS · Entity 88229 | SaleCommon Stock | 50,000 | $7.68 | $384,000.00 |
DisclosureSEC source: 0001562180-20-004579 · primarydocument.xml · nonDerivative · entry 2 Shealy Jeffrey B. · CIK 0001700683 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,946,062 F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan originally adopted by the reporting person on December 19, 2019 (as amended on May 15, 2020). F3 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.55 to $7.98, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 16, 2020 Filed Jun 18, 2020 16:49 UTC | Akoustis Technologies, Inc. AKTS · Entity 88229 | SaleCommon Stock | 50,000 | $8.01 | $400,500.00 |
DisclosureSEC source: 0001562180-20-004579 · primarydocument.xml · nonDerivative · entry 1 Shealy Jeffrey B. · CIK 0001700683 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,996,062 F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan originally adopted by the reporting person on December 19, 2019 (as amended on May 15, 2020). F2 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.82 to $8.12, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| April 02, 2020 Filed Apr 3, 2020 17:26 UTC | Akoustis Technologies, Inc. AKTS · Entity 88229 | SaleCommon Stock | 50,000 | $4.65 | $232,500.00 |
DisclosureSEC source: 0001562180-20-002895 · primarydocument.xml · nonDerivative · entry 2 Shealy Jeffrey B. · CIK 0001700683 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,046,062 F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan originally adopted by the reporting person on December 19, 2019. The shares were sold to fund federal and state individual tax obligations. F3 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.45 to $4.86, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| April 01, 2020 Filed Apr 3, 2020 17:26 UTC | Akoustis Technologies, Inc. AKTS · Entity 88229 | SaleCommon Stock | 50,000 | $4.72 | $236,000.00 |
DisclosureSEC source: 0001562180-20-002895 · primarydocument.xml · nonDerivative · entry 1 Shealy Jeffrey B. · CIK 0001700683 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,096,062 F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan originally adopted by the reporting person on December 19, 2019. The shares were sold to fund federal and state individual tax obligations. F2 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.50 to $5.10, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| March 26, 2020 Filed Mar 27, 2020 16:57 UTC | Akoustis Technologies, Inc. AKTS · Entity 88229 | SaleCommon Stock | 7,500 | $4.74 | $35,550.00 |
DisclosureSEC source: 0001562180-20-002732 · primarydocument.xml · nonDerivative · entry 2 Shealy Jeffrey B. · CIK 0001700683 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,146,062 F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 19, 2019, as amended. F3 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.46 to $5.04, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| March 25, 2020 Filed Mar 27, 2020 16:57 UTC | Akoustis Technologies, Inc. AKTS · Entity 88229 | SaleCommon Stock | 25,000 | $4.64 | $116,000.00 |
DisclosureSEC source: 0001562180-20-002732 · primarydocument.xml · nonDerivative · entry 1 Shealy Jeffrey B. · CIK 0001700683 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,153,562 F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 19, 2019, as amended. F2 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.47 to $4.80, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| March 13, 2020 Filed Mar 17, 2020 17:36 UTC | Akoustis Technologies, Inc. AKTS · Entity 88229 | SaleCommon Stock | 7,564 | $4.20 | $31,768.80 |
DisclosureSEC source: 0001562180-20-002585 · primarydocument.xml · nonDerivative · entry 1 Shealy Jeffrey B. · CIK 0001700683 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · by spouse Disclosed balance after: 0 F1 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.15 to $4.24, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 08, 2020 Filed Jan 10, 2020 16:06 UTC | Akoustis Technologies, Inc. AKTS · Entity 88229 | Disposition to issuerCommon Stock | 1,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-20-000320 · primarydocument.xml · nonDerivative · entry 1 Shealy Jeffrey B. · CIK 0001700683 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · by spouse Disclosed balance after: 7,564 F1 · kind: Represents shares under a restricted stock award forfeited upon the voluntary termination by the reporting person's spouse of her employment with the issuer. F2 · balance_after: Amount reflects forfeiture of 4,750 restricted stock units upon the voluntary termination of the reporting person's spouse of her employment with the issuer. Read SEC document |
| December 20, 2019 Filed Dec 26, 2019 17:11 UTC | Akoustis Technologies, Inc. AKTS · Entity 88229 | GrantStock Options (Right to buy) · Derivative | 30,000 | $0.00 Strike: $7.98 | $0.00 |
DisclosureSEC source: 0001562180-19-006269 · primarydocument.xml · derivative · entry 3 Shealy Jeffrey B. · CIK 0001700683 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2026-12-19 F1 · derivative.exercise_date: The Stock Options vest in five equal annual installments beginning on December 20, 2020. Read SEC document |
| December 20, 2019 Filed Dec 26, 2019 17:11 UTC | Akoustis Technologies, Inc. AKTS · Entity 88229 | GrantCommon Stock | 30,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-19-006269 · primarydocument.xml · nonDerivative · entry 1 Shealy Jeffrey B. · CIK 0001700683 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,178,562 Read SEC document |
| November 27, 2019 Filed Nov 27, 2019 17:23 UTC | Akoustis Technologies, Inc. AKTS · Entity 88229 | SaleCommon Stock | 5,000 | $7.62 | $38,100.00 |
DisclosureSEC source: 0001562180-19-005764 · primarydocument.xml · nonDerivative · entry 2 Shealy Jeffrey B. · CIK 0001700683 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,148,562 F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 20, 2019 (as amended on June 19, 2019). F3 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.52 to $7.71, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.